Cause-specific telomere factors deregulation in hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  El Idrissi, Manale ^a   Hervieu, Valérie ^b   Merle, Philippe ^c,d,e   Mortreux, Franck ^a   Wattel, Eric ^a,d  

^a CNRS   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Alcohol; Cirrhosis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Liver; Shelterin; Telomerase; Telomere

Indexed keywords

HMRE11A PROTEIN; HMRE11B PROTEIN; KU ANTIGEN; KU80 PROTEIN; PIN2 TRF1 INTERACTING TELOMERASE INHIBITOR 1; POT1 PROTEIN; PROTEIN; RAD50 PROTEIN; RAP1 PROTEIN; SHELTERIN; TANKYRASE; TANKYRASE 1; TELOMERASE; TELOMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; TIN2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE HOMEOSTASIS; TELOMERE LENGTH; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA; TELOMERASE; TELOMERE;

EID: 84883624045     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-64     Document Type: Article

References (40)

1. The global epidemiology of hepatocellular carcinoma: present and future. McGlynn KA, London WT, Clin Liver Dis 2011 15 223 243 vii-x 10.1016/j.cld.2011. 03.006 21689610
2. MicroRNAs involved in neoplastic transformation of liver cancer stem cells. Li R, Qian N, Tao K, You N, Wang X, Dou K, J Exp Clin Cancer Res 2010 29 169 10.1186/1756-9966-29-169 21176238
3. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. Begus-Nahrmann Y, Hartmann D, Kraus J, Eshraghi P, Scheffold A, Grieb M, Rasche V, Schirmacher P, Lee HW, Kestler HA, et al. J Clin Invest 2012 122 2283 2288 10.1172/JCI61745 22622037
4. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Farazi PA, Glickman J, Horner J, Depinho RA, Cancer Res 2006 66 4766 4773 10.1158/0008-5472.CAN-05-4608 16651430
5. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA, Cancer Res 2003 63 5021 5027 12941829 (Pubitemid 37022640)
6. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL, Hepatology 2004 40 80 86 15239089 (Pubitemid 38868926)
7. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP, et al. Hepatology 2007 45 968 976 10.1002/hep.21552 17393506 (Pubitemid 46631565)
8. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Plentz RR, Schlegelberger B, Flemming P, Gebel M, Kreipe H, Manns MP, Rudolph KL, Wilkens L, Hepatology 2005 42 522 526 10.1002/hep.20847 16116624 (Pubitemid 41233641)
9. PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. Lai XF, Shen CX, Wen Z, Qian YH, Yu CS, Wang JQ, Zhong PN, Wang HL, J Exp Clin Cancer Res 2012 31 12 10.1186/1756-9966-31-12 22316341
10. Extension of life-span by introduction of telomerase into normal human cells. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE, Science 1998 279 349 352 10.1126/science.279.5349.349 9454332 (Pubitemid 28063364)
11. Shelterin: the protein complex that shapes and safeguards human telomeres. De Lange T, Genes Dev 2005 19 2100 2110 10.1101/gad.1346005 16166375 (Pubitemid 41330312)
12. How telomeres are replicated. Gilson E, Geli V, Nat Rev Mol Cell Biol 2007 8 825 838 17885666 (Pubitemid 47462137)
13. A DNA damage checkpoint response in telomere-initiated senescence. D' Adda Di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP, Nature 2003 426 194 198 10.1038/nature02118 14608368 (Pubitemid 37442589)
14. The limited in vitro lifetime of human diploid cell strains. Hayflick L, Exp Cell Res 1965 37 614 636 10.1016/0014-4827(65)90211-9 14315085
15. The serial cultivation of human diploid cell strains. Hayflick L, Moorhead PS, Exp Cell Res 1961 25 585 621 10.1016/0014-4827(61)90192-6 13905658
16. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J, Nature 1995 375 503 506 10.1038/375503a0 7777060
17. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Stein GH, Drullinger LF, Soulard A, Dulic V, Mol Cell Biol 1999 19 2109 2117 10022898 (Pubitemid 29098269)
18. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S, The EMBO journal 1997 16 6018 6033 10.1093/emboj/16.19.6018 9312059 (Pubitemid 27427297)
19. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA, Nature 2000 406 641 645 10.1038/35020592 10949306 (Pubitemid 30641052)
20. A critical role for telomeres in suppressing and facilitating carcinogenesis. Artandi SE, DePinho RA, Curr Opin Genet Dev 2000 10 39 46 10.1016/S0959-437X(99)00047-7 10679392 (Pubitemid 30113704)
21. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Rudolph KL, Millard M, Bosenberg MW, DePinho RA, Nat Genet 2001 28 155 159 10.1038/88871 11381263 (Pubitemid 32538061)
22. Cis-activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. Horikawa I, Barrett JC, J Natl Cancer Inst 2001 93 1171 1173 10.1093/jnci/93.15.1171 11481390 (Pubitemid 32780970)
23. Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase. Liu H, Shi W, Luan F, Xu S, Yang F, Sun W, Liu J, Ma C, Virus Genes 2010 40 174 182 10.1007/s11262-009-0441-3 20107884
24. Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells. Qu ZL, Zou SQ, Cui NQ, Wu XZ, Qin MF, Kong D, Zhou ZL, World J Gastroenterol 2005 11 5627 5632 16237755 (Pubitemid 41684914)
25. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Su JM, Lai XM, Lan KH, Li CP, Chao Y, Yen SH, Chang FY, Lee SD, Lee WP, Hepatology 2007 46 402 413 10.1002/hep.21675 17559154 (Pubitemid 47344775)
26. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. Zhang X, Dong N, Zhang H, You J, Wang H, Ye L, J Lab Clin Med 2005 145 98 104 10.1016/j.lab.2004.11.018 15746653 (Pubitemid 40298736)
27. Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. Zou SQ, Qu ZL, Li ZF, Wang X, World J Gastroenterol 2004 10 2259 2262 15259077 (Pubitemid 39144979)
28. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Liu H, Luan F, Ju Y, Shen H, Gao L, Wang X, Liu S, Zhang L, Sun W, Ma C, Biochem Biophys Res Commun 2007 355 379 384 10.1016/j.bbrc.2007.01.160 17307151
29. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L, et al. Gut 2009 58 1528 1537 10.1136/gut.2008.174029 19651630
30. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells. Zhu Z, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, Schmidt WN, J Med Virol 2010 82 239 248 10.1002/jmv.21644 20029802
31. Shortened telomeres in individuals with abuse in alcohol consumption. Pavanello S, Hoxha M, Dioni L, Bertazzi PA, Snenghi R, Nalesso A, Ferrara SD, Montisci M, Baccarelli A, Int J Cancer 2011 129 983 992 10.1002/ijc.25999 21351086
32. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestkeeper-excel-based tool using pair-wise correlations. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP, Biotechnol Lett 2004 26 509 515 15127793 (Pubitemid 38448421)
33. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
34. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A, Liver Int 2009 29 1162 1170 10.1111/j.1478-3231.2009.02082.x 19627485
35. Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma. Guo Y, Zhou X, Liu E, Li X, Liu J, Yang Z, Yi J, J Huazhong Univ Sci Technolog Med Sci 2005 25 303 306 10.1007/BF02828150 16201279
36. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Oh BK, Kim YJ, Park C, Park YN, Am J Pathol 2005 166 73 80 10.1016/S0002-9440(10) 62233-X 15632001 (Pubitemid 40051661)
37. Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Lazzerini Denchi E, Celli G, De Lange T, Genes Dev 2006 20 2648 2653 10.1101/gad.1453606 17015429 (Pubitemid 44498375)
38. Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT. Hu Y, Shen Y, Ji B, Wang L, Zhang Z, Zhang Y, Eur J Pharm Sci 2011 42 387 391 10.1016/j.ejps.2011.01.004 21238587
39. A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. Greten TF, Forner A, Korangy F, N'Kontchou G, Barget N, Ayuso C, Ormandy LA, Manns MP, Beaugrand M, Bruix J, BMC Cancer 2010 10 209 10.1186/1471-2407-10-209 20478057
40. siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma. Guo X, Wang W, Zhou F, Lu Z, Fang R, Jia F, Bu X, Li R, Zhang B, Wu M, Wei L, Cancer Biol Ther 2008 7 1555 1560 10.4161/cbt.7.10.6539 18708758